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Inflammatory gene expression profiles in sporadic, familial and TREM2 variant Alzheimer’s disease 
Introduction: The underlying pathogenesis of Alzheimer’s disease (AD) remains elusive. However 
recent genetic observations indicate that neuroinflammation may play a role in the causative 
mechanism. Links have been identified between some inflammatory genes identified in GWAS 
studies and other genes specifically associated with AD such as APOE and TREM2, providing further 
reasoning to investigate the role of neuroinflammation in AD. Here we explore the gene expression 
profiles of 256 inflammatory genes in post-mortem AD brains of sporadic and familial origin. 
Material and methods: The frontal cortex from post-mortem brain samples were collected from 
sporadic AD cases (n=10), familial AD cases (n=7), TREM2 variant cases (n=7) and neurologically 
normal controls (n=6). RNA was extracted and quality checked using the Qiagen RNeasy kit and 
Eppendorf spectrophotometer. The samples were analysed using the human inflammation panel 
(NanoString Technologies) and an additional 30 genes already identified to be implicated in AD. 
Results: 286 genes were successfully processed and analysed using NanoString Technologies nSolver 
software. All pairwise comparisons were made and T-tests completed with a number of significant 
gene expression changes. When compared to controls, 126 genes had statistically different 
expression levels (p<0.05) in sporadic AD cases, 93 genes in familial AD cases and 57 genes in the 
TREM2 variant cases. The expression profile of the TREM2 variant group overlapped with the 
sporadic AD cases. Pathway analysis were performed using WebGestalt to look at GO (gene 
ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) analyses. 
Conclusions: As predicted there is a strong inflammatory component to AD with differing expression 
of inflammatory markers. This suggests that neuroinflammation plays a large role in AD 
pathogenesis. Inflammatory gene expression also differs between sporadic AD cases and familial AD 
cases indicating that the two disease groups may not share a common inflammatory response 
pathway. Further investigations into the individual gene targets and their mechanisms of action in 
AD pathogenesis are needed to identify their influence on the underlying disease mechanisms.  
